Treating asthma means treating airway smooth muscle cells

Publisher:
European Respiratory Society
Publication Type:
Journal Article
Citation:
European Respiratory Journal, 2008, 32 (2), pp. 265 - 274
Issue Date:
2008-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2011006488OK.pdf341.09 kB
Adobe PDF
Asthma is characterised by airway hyperresponsiveness, airway inflammation and airway remodelling. Airway smooth muscle cells are known to be the main effector cells of airway narrowing. In the present paper, studies will be discussed that have led to a novel view of the role of airway smooth muscle in the pathogenesis of asthma in which airway hyperresponsiveness, remodelling and inflammation are, at least in part, attributable to airway smooth muscle. Furthermore, how this new view may lead to a change in the phenotyping and treatment of patients with asthma will be discussed.
Please use this identifier to cite or link to this item: